Trials / Completed
CompletedNCT03627455
Troponin I and T and Adverse Outcomes in Patients With and Without Diabetes Mellitus After Coronary Intervention
A Sex-specific Analysis of the Predictive Value of Troponin I and T in Patients With and Without Diabetes Mellitus After Successful Coronary Intervention
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 818 (actual)
- Sponsor
- Wilhelminenspital Vienna · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Elevated levels of troponin are associated with future MACE. Data on the prognostic value of high sensitive troponin T (hs-TnT) as compared to high sensitive troponin I (hs-TnI) in diabetic and non-diabetic patients are sparse. We aimed to assess the risk for MACE according to gender and diabetes status and to compare the prognostic value of hs-TnT and hs-TnI with regards to clinical outcomes in diabetic and non-diabetic patients undergoing percutaneous coronary intervention (PCI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Percutaneous coronary intervention | Percutaneous coronary intervention |
Timeline
- Start date
- 2003-01-01
- Primary completion
- 2017-12-31
- Completion
- 2017-12-31
- First posted
- 2018-08-13
- Last updated
- 2018-08-14
Source: ClinicalTrials.gov record NCT03627455. Inclusion in this directory is not an endorsement.